Αποτελέσματα Αναζήτησης
26 Φεβ 2024 · The study, published in Vaccine, confirmed previously identified rare safety signals for myocarditis and pericarditis after a mRNA vaccine (Pfizer and Moderna) and Guillain-Barré syndrome and cerebral venous sinus thrombosis (CVST) after viral vector vaccines (AstraZeneca).1
27 Φεβ 2024 · A study published Feb. 12 in the journal Vaccine reported on an international group of more than 99 million people who received COVID-19 vaccines, primarily finding links to known rare side...
Vaccination has been found to increase the risk of Bell's palsy, and COVID-19 immunization has been reported to cause 19,529 neurological adverse effects, including facial paralysis. 58 Patients have experienced facial paralysis after immunization with the Oxford-AstraZeneca, Pfizer, Moderna, Sputnik V, and Johnson & Johnson COVID-19 vaccines.
1. Cases of apparent secondary immune thrombocytopenia (ITP) after SARS‐CoV‐2 vaccination with both the Pfizer and Moderna versions have been reported and reached public attention.
25 Οκτ 2021 · Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to regulatory, clinical and public health concerns.
27 Μαρ 2023 · Here, we show there is no significant increase in cardiac or all-cause mortality in the 12 weeks following COVID-19 vaccination compared to more than 12 weeks after any dose.
24 Σεπ 2021 · Novel vaccines against SARS-CoV-2 are being used globally. •. Serious incidents have been reported after adeno-vectored SARS-CoV-2 vaccination. •. The reports include severe thrombosis and thrombocytopenia. •. Mild bleeding is more prevalent after ChAdOx1 nCoV-19 than mRNA vaccination. •.
